Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 Billion in a Series C funding round.
This article has been indexed from AI News & Artificial Intelligence | TechCrunch

Read the original article:

Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials